What is the dosage of Fabrazyme?

Fabrazyme is available in 2 dosages, including 35 mg Injection and 5 mg Injection

What is Fabrazyme made of?

Fabrazyme contains agalsidase beta which is a Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme

How is Fabrazyme administered?

Fabrazyme is administered as a Injectable

What is Fabrazyme mechanism of action?

Fabrazyme mechanism of action is

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Fabrazyme

(agalsidase beta)

agalsidase beta 35 MG Injection [Fabrazyme]agalsidase beta 5 MG Injection [Fabrazyme]

NO BLACK BOX WARNING

Dosage & administration

* The recommended dosage is 1 mg/kg body weight given every two weeks as an intravenous infusion.
* Ensure appropriate medical support is available when Fabrazyme is administered because of the potential for anaphylaxis and severe infusion-associated reactions.
* Administer antipyretics prior to infusion.
* See the full prescribing information for the recommended infusion rate.

Fabrazyme prescribing information

Have more Fabrazyme questions?

Submit MSL Request

Learn More

Need to report a Fabrazyme issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Fabrazyme Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Fabrazyme Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Charitable Access Program ( Phone number to request application form)

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Charitable Access Program ( Phone number to request application form)

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Fabrazyme Patient education

Getting started on Fabrazyme

NOT PROVIDED BY BRANDInstructions For Use - Fabry Disease

Patient toolkit

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

About Fabrazyme

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Fabrazyme FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Fabrazyme

Dosage & administration

Most viewed Fabrazyme resources

drug label

Fabrazyme prescribing information

Have more Fabrazyme questions?

Need to report a Fabrazyme issue?

prior authorization

Fabrazyme Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Fabrazyme Financial assistance options

Co-pay savings program

Overview

Patient benefit

Patient eligibility

How to sign up

Bridge program

Overview

Patient benefit

Patient eligibility

How to sign up

Foundation programs

Overview

Patient benefit

Patient eligibility

How to sign up

patient education

Fabrazyme Patient education

Getting started on Fabrazyme

Patient toolkit

people also ask

Fabrazyme FAQs

Can't find what you're looking for?